Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × pazopanib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 9 Sarcoma 8 Sarcoma, Clear Cell 2 Neurofibrosarcoma 2 Nerve Sheath Neoplasms 2 Neoplasm Metastasis 2 Liposarcoma 2 Histiocytoma, Angiomatoid Fibrous 2 Granuloma, Plasma Cell 2 Glioblastoma 2 Fibrosarcoma 2 Dermatofibrosarcoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Vascular Neoplasms 1 Solitary Fibrous Tumors 1 Solid Tumor, Adult 1 Solid Neoplasm 1 Smooth Muscle Tumor 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Perivascular Epithelioid Cell Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neuroendocrine Tumors 1 Neoplasms, Adipose Tissue 1 Myoepithelioma 1 Liposarcoma, Myxoid 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1

Interventions

Vemurafenib 4 selpercatinib 3 Magnetic Resonance Spectroscopy 3 trametinib 2 entrectinib 2 dabrafenib 2 cobimetinib 2 X-Rays 2 Specimen Handling 2 tremelimumab 1 tovorafenib 1 spartalizumab 1 pralsetinib 1 pembrolizumab 1 lenvatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 copanlisib 1 cabozantinib 1 Whole Body Imaging 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Sunitinib 1 Robotic Surgical Procedures 1 Radiofrequency Ablation 1 Postoperative Period 1 Pharmacogenomic Testing 1 Phantoms, Imaging 1 Mitoxantrone 1 Iodine-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡